Clinical trial
Antidepressant Treatment of Mexican-Americans: UCLA Pharmacogenetics and…
NCT00265291 · National Institute of General Medical Sciences (NIGMS), NIH · Completed
Key facts
| NCT number | NCT00265291 |
|---|---|
| Title | Antidepressant Treatment of Mexican-Americans: UCLA Pharmacogenetics and Pharmacogenomics Research Group |
| Lead sponsor | National Institute of General Medical Sciences (NIGMS), NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Major Depressive Disorder, Major Depression, Unipolar Depression |
| Intervention type | Drug |
| Interventions | fluoxetine or desipramine |
| Enrollment | 700 |
| Start date | Nov 1, 1999 |
| Primary completion | May 1, 2006 |
| Completion | Oct 1, 2008 |
| First posted | Dec 14, 2005 |
| Last update posted | Oct 10, 2008 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: